OpenBilldrug price receipt

NADAC week of 2026-10-14

LITHOBID ER 300 MG TABLET

FDA nonproprietary name: lithium carbonate

For 30 tablets

Pharmacies pay

$360.58 filed

30 × $12.01942 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$419.67 estimated

$360.58 + $54.09 (15%) + $5.00 fee per fill = $419.67

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

LITHOBID ER 300 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lithium carbonate, under the trade name “LITHOBID”.

FDA gives its dosage form as tablet, film coated, extended release and its route as oral.

The labeler, the company named on the label, is ANI Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Mood Stabilizer.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 62559-0280-01.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $360.58 for 30 tablets (30 × $12.01942 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.1963 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

The NDC

Other strengths, forms and brands

6 other products in the NADAC file share the FDA nonproprietary name lithium carbonate with LITHOBID ER 300 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
LITHIUM CARBONATE 150 MG CAP
generic · capsule, gelatin coated / capsule
$0.09634 per EA filed
eff. 2026-09-23
$0.13711 per EA filed
Part D 2024 average
LITHIUM CARBONATE 300 MG CAP
generic · capsule, gelatin coated / capsule
$0.10387 per EA filed
eff. 2026-09-23
$0.13711 per EA filed
Part D 2024 average
LITHIUM CARBONATE 300 MG TAB
generic · tablet
$0.19092 per EA filed
eff. 2026-09-23
$0.13711 per EA filed
Part D 2024 average
LITHIUM CARBONATE 600 MG CAP
generic · capsule, gelatin coated / capsule
$0.24258 per EA filed
eff. 2026-09-23
$0.13711 per EA filed
Part D 2024 average
LITHIUM CARBONATE ER 300 MG TB
generic · tablet, extended release / tablet, film coated, extended release
$0.1963 per EA filed
eff. 2026-09-23
$0.2185 per EA filed
Part D 2024 average
LITHIUM CARBONATE ER 450 MG TB
generic · tablet, extended release / tablet
$0.25902 per EA filed
eff. 2026-09-23
$0.2185 per EA filed
Part D 2024 average
LITHOBID ER 300 MG TABLET this page
brand · tablet, film coated, extended release
$12.01942 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $12.01942 per EA filed.

Of the 72 other products in FDA’s Mood Stabilizer class priced per EA, 11 have a higher middle NADAC price and 61 a lower one. The one in the middle is LAMOTRIGINE ER 300 MG TABLET, at $1.25965 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.